NESAN – The Neurodiversity Self-Advocacy Network
A Project of Neurodiversity International (NDI)
|
Accessibility | Home | ND-TV | News | About | APANA | Health and Social Care | Events | Contact | Nutrition and Behaviour | Campaigns | DAN | Disability Hate Crimes | Services and Training | Support | Inclusive Living and Education | Links | Site Map | Translate | ARMUK | DISCLAIMER |
|
NESAN – The Neurodiversity Self-Advocacy Network A Project of Neurodiversity International (NDI) |
|
Approval process lowers the number of
kids on atypical prescriptions(USA)
By Kris Hundley, Times Staff Writer,
St.
Petersburg Times
Sunday, March 29, 2009 Nudged by public pressure, Florida health officials took a baby step last year toward reining in the use of powerful antipsychotic drugs among children: They began requiring that doctors get approval before giving these drugs to kids under 6 on the Medicaid program. That simple step prompted a seismic change in doctors' prescribing habits. The number of prescriptions of these potent drugs to kids in this age group plummeted nearly 75 percent. Another dramatic change: Nearly 40 percent fewer doctors are even bothering to write prescriptions for these drugs including Risperdal, Abilify, Seroquel and Zyprexa apparently finding alternatives that require less paperwork. |
||
|
|
||
|
|
